DrugDashboards

Olmesartan Medoxomil

Olmesartan Medoxomil · OLMESARTAN MEDOXOMIL 20 mg/1 · Tablet, Coated · Oral · Ascend Laboratories, LLC

NDC 67877-0446-74 · 5 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for olmesartan medoxomil (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA206763
TE code
AB
Approval date
Apr 24, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedApr 29, 2021
    Ascend Laboratories LLC — Presence of Foreign Tablet/Capsule
  • Class II · TerminatedJan 24, 2020
    Ascend Laboratories LLC — cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.

Manufacturers of Olmesartan Medoxomil (Tablet, Coated)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 3, 2026
Ascend Laboratories, LLCOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Inventia Healthcare LimitedOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Inventia Healthcare LimitedOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Inventia Healthcare LimitedOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olmesartan Medoxomil — NDC 67877-0446-74," retrieved September 3, 2026, https://drugdashboards.com/drug/67877044674.

Free to cite with attribution — see how the data is put together.